Appointment of joint corporate brokersSource: RNS
9 May 2022 13:00 BST
Appointment of joint corporate brokers
AstraZeneca PLC announced that its joint corporate brokers will be Morgan Stanley & Co. International plc and J.P. Morgan Securities plc (which conducts its UK investment banking business as J.P. Morgan Cazenove), effective as of 9 May 2022.
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.